Stem cells are special cells that have the ability to develop into other essential cells, often stimulating wound healing and encouraging cell strengthening. This makes Stem Cell therapy highly regarded in its use to treat or prevent skin conditions. Cambridge’s Advanced STEMCELL therapy uses Cord Lining Stem Cells that is both HSA and Japanese FDA approved. It is a 1st-of-its-kind STEMCELL therapy that is both proven and safe. Using StemCell serum of 80% potency, this 4 session program comes with its own high-potency StemCell cream for home-care to further strengthen skin and speed up its anti-ageing and healing abilities.
After only 4 weeks, this therapy visibly restores the natural balance of both epidermal and dermal layers of the skin, restoring your skin’s health, firmness and elasticity.
This therapy was researched in collaboration with CORDLife – Singapore’s premier bio-science corporation that pioneers in Cord Lining Stem Cell for regenerative medicine and therapy. A 4-week program has effectively proven to restore 1Skin Fullness & Elasticity, 2Accelerate Skin Recovery, 3Reduce fine lines, 4Lighten Pigmentation and 5Improve Epidermal Translucency as old pigmentation cells are shed.
- Suitable for: All skin types except active acne
- Initial Recommended Interval: Once per week
- Maintenance Interval: Every 3 months
Did you know?
Normal skin stem cell turnover is between 28 to 30 days. Stem cells, like the other parts of the human body, can age too. When that happens its job of skin regeneration is done less effectively taking up to 40 days for the skin to renew. As a result, the signs of aging which we are all too familiar with, like skin thinness, wrinkle lines, pigmentation and dryness, begin to appear.
By replenishing the proteins that skin stem cell no longer produce in adequate quantities, it encourages skin cells to renew every 28 to 30 days, restoring normal and healthy skin cell turnover.
THE UNIQUE FORMULATION
391 Orchard Road, #08-05A2 Ngee Ann City Tower B, Singapore 238874
T: 6733 6729
For more information or to arrange a media trial, please contact: